Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,624,070
+$15,179,754 QoQ
Shares Held
371,568
+3.2% QoQ
Ownership
0.366%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#49
of 768 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $248,215,917 across 22 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,374,683 | $69,469,966 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
371,568 | $62,624,070 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
79,123 | $42,871,215 | |
| 4 | ZTS |
Zoetis Inc.
|
531,415 | $38,187,481 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
465,714 | $11,461,221 | |
| 6 | PRGO |
PERRIGO Co plc
|
435,648 | $4,526,382 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
94,850 | $3,891,695 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
76,441 | $2,767,164 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,624,070 | 371,568 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,444,316 | 360,136 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,908,566 | 168,572 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,141,374 | 136,354 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,454,004 | 91,129 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,431,143 | 31,023 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $779,961 | 5,714 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,764,824 | 15,317 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,269,869 | 38,279 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $731,527 | 5,304 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $729,686 | 5,538 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $569,025 | 5,058 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $510,445 | 5,413 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $768,563 | 7,593 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $935,095 | 7,829 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $597,431 | 5,625 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $545,498 | 5,596 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $658,406 | 7,023 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $217,864 | 2,558 | Shares | Sole | 2022-02-14 | |
| 2020-09-30 | $1,799,345 | 18,712 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,566,724 | 12,842 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,662,192 | 19,205 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||